United Kingdom · Question · Written question
UIN 30537
Givinostat
Introduced
10 February 2025
Last action
25 February 2025 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
25 February 2025
Summary
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of approving Givinostat for use to treat Duchenne Muscular Dystrophy in (a) Royal Cornwall Hospital Trust and (b) other NHS trusts.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
10 February 2025
Written question
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of approving Givinostat for use to treat Duchenne Muscular Dystrophy in (a) Royal Cornwall Hospital Trust and (b) other NHS trusts.
Source: Commons
25 February 2025
Answer
The National Institute for Health and Care Excellence (NICE) makes recommendations for the National Health Service on whether new licensed medicines should be routinely funded by the NHS independently based on an assessment of their costs and benefits. Th...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2025-02-10/30537
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1764199
- uk · wq-1764199 · source updated 25 February 2025